Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) major shareholder Guy Levy acquired 500,000 shares of Parabilis Medicines stock in a transaction on Thursday, June 11th. The shares were purchased at an average cost of $20.00 per share, with a total value of $10,000,000.00. Following the completion of the purchase, the insider directly owned 1,027,000 shares of the company’s stock, valued at approximately $20,540,000. This represents a 94.88% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Parabilis Medicines Stock Down 6.2%
PBLS stock opened at $27.37 on Wednesday. Parabilis Medicines, Inc. has a 52-week low of $24.51 and a 52-week high of $34.47.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised shares of Parabilis Medicines to a “hold” rating in a research note on Saturday, June 20th.
Featured Stories
- Five stocks we like better than Parabilis Medicines
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
